Establishment of a pathomic-based machine learning model to predict CD276 (B7-H3) expression in colon cancer
CD276 is a promising prognostic indicator and an attractive therapeutic target in various malignancies. However, current methods for CD276 detection are time-consuming and expensive, limiting extensive studies and applications of CD276. We aimed to develop a pathomic model for CD276 prediction from...
Main Authors: | Jia Li, Dongxu Wang, Chenxin Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1232192/full |
Similar Items
-
Decreased m6A Modification of CD34/CD276(B7-H3) Leads to Immune Escape in Colon Cancer
by: Yiran Zhou, et al.
Published: (2021-07-01) -
CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer
by: Kinga Hińcza-Nowak, et al.
Published: (2023-06-01) -
Development and Validation of a Pathomics Model Using Machine Learning to Predict Expression and Prognosis in Head and Neck Cancer
by: Weihua Wang, et al.
Published: (2024-02-01) -
Large-scale extraction of interpretable features provides new insights into kidney histopathology – A proof-of-concept study
by: Laxmi Gupta, et al.
Published: (2022-01-01) -
The Role of CD276 in Cancers
by: Shengzhuo Liu, et al.
Published: (2021-03-01)